A 61-year-old manwith liver cirrhosis showeda symmetrical increase in the signal intensity of the basal ganglia on Tl-weighted magnetic resonance (MR) images, which was diminished after 3 months of treatment for hepatic encephalopathy. He recovered from encephalopathy with treatment, and liver dysfunction (hyperammonemia and abnormal blood coagulation) as well as the results of quantitative psychometric tests showed a marked improvement. The cause of these high signal intensity changes on Tl-weighted images and the reason for their partial reversibility are not known, but hyperammonemiadue to portal-systemic shunting might be closely related to these clinical observations.
Introduction
Hepatic encephalopathy is considered to be a functional (metabolic) and reversible condition, and no organic changes in the central nervous system have been described in relation to this type of encephalopathy. The recent widespread use of computed tomography (CT) and magnetic resonance (MR) imaging has revealed that cerebral atrophy and edemais sometimes observed in alcoholic and nonalcoholic cirrhotic patients both with and without hepatic encephalopathy (1, 2) . In 1991, Inoue et al (3) reported that basal ganglia lesions producing a high signal intensity on MRimages are closely related to portal-systemic encephalopathy in cirrhotic patients. Interestingly, the same findings were observed even in cases with subclinical encephalopathy. However, it is still unknownwhether or not these cerebral morphologic changes are causally related to neuropsychiatric symptomsand abnormalities of quantitative psychometric tests.
The present report describes the diminution of the increased signal intensity in the basal ganglia in Tlweighted MRimages in a cirrhotic patient with hepatic encephalopathy whoreceived intensive treatment. The cause and the potential clinical significance of these clinical observations are discussed.
Case Report
A 61-year-old manwas admitted to our hospital with hematemesis on May1, 1991. On admission, drowsiness and flapping tremor were present, and he had hepatic encephalopathy with grade II coma according to Sherlock's classification (4) . Mild anemia, slight icterus, and ascites were also present. The liver, which was very firm, was palpable at two fingerbreadths below the xyphoid process of the sternum. Splenomegaly, pretibial edema, or superficial venous dilatation on the abdominal wall were not observed on admission. In 1980, he had received a blood transfusion at the time of skin grafting for burns. He had a past history of a daily intake of >25 g of ethanol from 1965 to 1981, but he had been abstinent for the 10 years before admission. Endoscopic sclerotherapy of the esophageal varices was performed three times, and the bleeding was completely arrested. From 2-5 days after admission, his encephalopathy worsened up to coma grade V (Fig. 1) . However thereafter the hepatic encephalopathy gradually improved and finally resolved in response to intensive therapy, including the intravenous infusion of a branchedchain amino acid-rich solution (AminolebanR) and oral administration of lactulose. Markedimprovementof liver dysfunction was observed in the changes of the serum cholinesterase activity and blood coagulation tests. From the 40th day after admission, blood ammonia levels remained constantly in the normal range with the patient on a low-protein diet (40g/day). Celiac arteriography was also performed to evaluate portal-systemic collateral vessels. Portography during the venous phase showed a large paraumbilical vein, and thus he was suspected to have portal-systemic encephalopathy. The first MRimages were obtained when his coma was grade II (June 9, 1991) and imaging was repeated when he had no apparent encephalopathy in the fifth month of admission (September 14, 1991) ( Fig. 1 and Table 2 ). MRimaging was performed with a 1.5-T superconducting system (Magnetom; Siemens, Erlangen, Germany) using Tl-and T2-weighted spin echo sequences of500/15 and 3,000/15 (repetition time/echo time, msec), respectively. Sequential slices of 7mmwere obtained with a 1.4-mm slice gap. Signal intensity changes on Tl-weighted MRimages were bilateral and symmetrical in the basal ganglia (Fig. 2) . The globus pallidus was markedly hyperintense relative to the surrounding gray and white matter. Corresponding T2-weighted images showed a normal low signal intensity in the basal ganglia. There was no evidence of any mass effect, and no enhancementwas seen after administration of gadopentetate dimeglumine. No abnormal findings were present on CTscans. In control patients without liver disease, the basal ganglia including the globus pallidus were isointense relative to the surrounding structures on Tl-weighted MRimages. The high intensity of the basal ganglia on Tl-weighted MRimages was partly diminished at 3 months after admission following extensive therapy, at a time when his liver function and quantitative psychometric test scores were markedly improved (Table 2 ). However, they were still not within the normal range, suggesting the presence of subclinical encephalopathy. The lowprotein diet was supplemented with a branched chain amino acid-enriched product (Aminoleban ENR), and lactulose was also continuously administered to prevent the recurrence of hepatic encephalopathy. At discharge on April 5, 1992, he was able to perform normal daily activities without hindrance. Cranial MRimaging was repeated on August 26, 1992, and showed almost the same Tl-weighted MRfeatures as on September 14, 1991.
Discussion
The high intensity changes in the basal ganglia on MR images are a new finding in addition to the previous observations of brain atrophy and edema as organic abnormalities of the central nervous system in cirrhotic patients with hepatic encephalopathy (1, 2) . The site of the earliest and most profound involvement seems to be the globus pallidus on the basis of Tl-weighted MR images. According to previous reports (3, 5), the caudate nucleus, internal capsule, and subthalamic nucleus are less consistently affected in hepatic encephalopathy. Further studies are needed to clarify whether clinical signs differ depending on the site of MRlesions in the brain. T2-weighted images show a normal low signal intensity in many cases (3), but hyperintensity of the T2 images was observed in some patients with chronic persistent encephalopathy (5).
Hyperintensity of the basal ganglia on Tl-weighted MRimages was also seen in patients on long-term total parenteral nutrition (TPN) (6) and patients with Wilson' s disease (pathologic deposition of copper) (7). Other reported causes of such hyperintensity include hemorrhage (methemoglobin) (8), melanoma (melanin) (9), dense calcification (10), and neurofibromatosis (ll). The present patient did not receive long-term TPN (i.e., longer than 5 months) and had no abnormalities of copper metabolism. CT scans were also normal. Therefore, the hepatic dysfunction and portal-systemic collateral shown. The Tl-weighted MRimage reveals no increase of the signal intensity in the basal ganglia. The high signal intensity on Tl-weighted MRimages was partly diminished at the second examination performed 3 months later after extensive therapy. Note that the areas of high signal intensity are narrowed on the second Tl-weighted image.
vessels observed in this patient suggest that the high intensity change on MRimages was produced by a certain mechanismrelated to liver cirrhosis. Hyperintensity on MRimages might be related to the proliferation of astrocytic glial cells (Alzheimer type II cells) in the basal ganglia, because ultrastructural changes such as proliferation of mitochondria, rough endoplasmic reticulum and vacuoles may cause Tl shortening (3). Gliosis in cirrhotic patients is considered to be secondary to long-term hyperammonemia (12).
Another possible cause of signal-intensity alterations on Tl-weighted MRimages is manganese deposition in the basal ganglia. Manganese is a paramagnetic transition metal that produces an increased signal intensity on Tlweighted MRimages (6) and also causes an astrogliotic reaction (13).
A cirrhotic liver with portal-systemic shunting maynot efficiently remove manganese from the blood and prevent its deposition in brain tissue (6), although the brain manganesecontent has not actually been studied in cirrhotic patients. The episode of hepatic encephalopathy in the present patient might have been triggered by transient hypoperfusion of the liver due to esophageal bleeding. However, there was elevation of blood ammonialevels following dietary protein overload (protein intolerance) and his psychometric tests were consistently abnormaleven after the disappearance of clinical encephalopathy, suggesting that our patient had portal-systemic encephalopathy.
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The partial diminution of the high intensity changes on MR-T1images might have been related to the improvement of liver dysfunction to the pre-episodal state and the maintenance of blood ammonialevels within the normal range by treatment. Manganese deposition could have transiently increased in the basal ganglia at the onset of severe encephalopathy, with the duration of manganese retention being insufficient to induce astrocyte proliferation.
Thus, the diminution of Tl shortening was possibly caused by the clearance of manganese during treatment, but this could not be confirmed.
After the initial period, no further diminution of the hyperintense changes on MR-T1images was observed during the long-term maintenance of normal blood ammonialevels. A previous report (14) 
